Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Biomarker Discovery & Development | Whitepapers & Reports

ALMAC - Consensus Gene Expression Analysis to Identify Key Hallmarks of Cancer in Malignant Melanoma

28 February 2023

Traditionally, gene expression signatures (GES) are used individually to classify patients into molecular subgroups.

Open document in a new tab

Related Resources

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Read More

Abcam: Keep your research moving with our tools

Read More

Unlock access to the latest research insights

Read More